Potential Shareholder Loan
Genedrive PLC announced that it is in discussions with David Nugent, a 16% shareholder, regarding a potential shareholder loan. Nugent has indicated a willingness to provide a direct cash injection into the company of up to £1 million. The terms of this potential loan are yet to be agreed upon. While there is no certainty that the funding will be received, the company welcomes this indication of financial support. Further announcements regarding this matter will be made in due course.
Select text to share a quote on X · sign in to keep highlights & notes in your GDR notes
genedrive plc (AIM: GDR), the point-of-care pharmacogenetic testing company, today announces an update regarding discussions with David Nugent, a 16% shareholder in the Company including via a limited company.
Since the Company's general meeting on 15 October 2025 the Company has continued to engage constructively with David Nugent around financing options for the Company and to this end he has recently indicated a willingness to make a direct cash injection into the Company by way of a loan of up to £1 million on terms to be agreed between the parties. Whilst there can be no certainty that this additional funding will be received the Company welcomes this indication of potential additional financial support from David Nugent and further announcements will be made in due course.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.